MLL: a histone methyltransferase disrupted in leukemia

Ayton, 2001, Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins, Oncogene, 20, 5695, 10.1038/sj.onc.1204639 Ayton, 2001, MLL in normal and malignant hematopoiesis, 447 Felix, C.A. et al. (2000) Pediatric acute lymphoblastic leukemia: Challenges and controversies in 2000. Hematology (Am. Soc. Hematol. Educ. Program), 285–302 Lochner, 1996, A specific deletion in the breakpoint cluster region of the ALL-1 gene is associated with acute lymphoblastic T-cell leukemias, Cancer Res., 56, 2171 Felix, 1998, Secondary leukemias induced by topoisomerase-targeted drugs, Biochim. Biophys. Acta, 1400, 233, 10.1016/S0167-4781(98)00139-0 Grimwade, 1998, The importance of diagnostic cytogenetics in outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukemia Working Parties, Blood, 92, 2322, 10.1182/blood.V92.7.2322 Schichman, 1994, ALL-1 partial duplication in acute leukemia, Proc. Natl. Acad. Sci. U. S. A., 91, 6236, 10.1073/pnas.91.13.6236 Poppe, 2004, Expression analyses identify MLL as a prominent target of 11q23 amplification and support an etiologic role for MLL gain of function in myeloid malignancies, Blood, 103, 229, 10.1182/blood-2003-06-2163 Brock, 2001, The Polycomb group – no longer an exclusive club?, Curr. Opin. Genet. Dev., 11, 175, 10.1016/S0959-437X(00)00176-3 Hess, 1997, Defects in yolk sac hematopoiesis in Mll-null embryos, Blood, 90, 1799, 10.1182/blood.V90.5.1799 Yagi, 1998, Growth disturbance in fetal liver hematopoiesis of Mll-mutant mice, Blood, 92, 108, 10.1182/blood.V92.1.108.413k11_108_117 Ernst, 2004, Definitive hematopoiesis requires the mixed-lineage leukemia gene, Dev. Cell, 6, 437, 10.1016/S1534-5807(04)00061-9 Yu, 1995, Altered Hox expression and segmental identity in Mll-mutant mice, Nature, 378, 505, 10.1038/378505a0 Hsieh, 2003, Proteolytic cleavage of MLL generates a complex of N- and C-terminal fragments that confers protein stability and subnuclear localization, Mol. Cell. Biol., 23, 186, 10.1128/MCB.23.1.186-194.2003 Hsieh, 2003, Taspase1: a threonine aspartase required for cleavage of MLL and proper HOX gene expression, Cell, 115, 293, 10.1016/S0092-8674(03)00816-X Nakamura, 2002, The ALL-1 protein is a histone H3- lysine 4 methyltransferase and assembles a supercomplex of proteins involved in chromatin alterations and in core promoter recognition, Mol. Cell, 10, 1119, 10.1016/S1097-2765(02)00740-2 Yokoyama, 2002, Leukemia proto-oncoprotein MLL is proteolytically processed into two fragments with opposite transcriptional properties, Blood, 100, 3710, 10.1182/blood-2002-04-1015 Yano, 1997, Nuclear punctate distribution of ALL-1 is conferred by distinct elements at the N terminus of the protein, Proc. Natl. Acad. Sci. U. S. A., 94, 7286, 10.1073/pnas.94.14.7286 Birke, 2002, The MT domain of the proto-oncoprotein MLL binds to CpG-containing DNA and discriminates against methylation, Nucleic Acids Res., 30, 958, 10.1093/nar/30.4.958 Yokoyama, 2004, Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression, Mol. Cell. Biol., 24, 5639, 10.1128/MCB.24.13.5639-5649.2004 Hughes, 2004, Menin associates with a trithorax family methyltransferase complex and with the Hoxc8 locus, Mol. Cell, 13, 587, 10.1016/S1097-2765(04)00081-4 Xia, 2003, MLL repression domain interacts with histone deacetylases, the polycomb group proteins HPC2 and BMI-1, and the corepressor C-terminal-binding protein, Proc. Natl. Acad. Sci. U. S. A., 100, 8342, 10.1073/pnas.1436338100 Fair, 2001, Protein interactions of the MLL PHD fingers modulate MLL target gene regulation in human cells, Mol. Cell. Biol., 21, 3589, 10.1128/MCB.21.10.3589-3597.2001 Ernst, 2001, MLL and CREB bind cooperatively to the nuclear coactivator CREB-binding protein, Mol. Cell. Biol., 21, 2249, 10.1128/MCB.21.7.2249-2258.2001 Milne, 2002, MLL targets SET domain methyltransferase activity to Hox gene promoters, Mol. Cell, 10, 1107, 10.1016/S1097-2765(02)00741-4 Lachner, 2002, The many faces of histone lysine methylation, Curr. Opin. Cell Biol., 14, 286, 10.1016/S0955-0674(02)00335-6 Muller, 2002, Histone methyltransferase activity of a Drosophila polycomb group repressor complex, Cell, 111, 197, 10.1016/S0092-8674(02)00976-5 Kuzmichev, 2002, Histone methyltransferase activity associated with a human multi-protein complex containing the enhancer of Zeste Protein, Genes Dev., 16, 2893, 10.1101/gad.1035902 Czermin, 2002, Drosophila enhancer of Zeste/ESC complexes have a histone H3 methyltransferase activity that marks chromosomal polycomb sites, Cell, 111, 185, 10.1016/S0092-8674(02)00975-3 Cao, 2002, Role of histone H3 lysine 27 methylation in Polycomb-group silencing, Science, 298, 1039, 10.1126/science.1076997 Zegerman, 2002, Histone H3 lysine 4 methylation disrupts binding of nucleosome remodeling and deacetylase (NuRD) repressor complex, J. Biol. Chem., 277, 11621, 10.1074/jbc.C200045200 Santos-Rosa, 2003, Methylation of histone H3 K4 mediates association of the Isw1p ATPase with chromatin, Mol. Cell, 12, 1325, 10.1016/S1097-2765(03)00438-6 Krogan, 2003, The Paf1 complex is required for histone H3 methylation by COMPASS and Dot1p: linking transcriptional elongation to histone methylation, Mol. Cell, 11, 721, 10.1016/S1097-2765(03)00091-1 Rozenblatt-Rosen, 1998, The C-terminal SET domains of ALL-1 and TRITHORAX interact with the INI1 and SNR1 proteins, components of the SWI/SNF complex, Proc. Natl. Acad. Sci. U. S. A., 95, 4152, 10.1073/pnas.95.8.4152 Corral, 1996, An Mll–AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes, Cell, 85, 853, 10.1016/S0092-8674(00)81269-6 Dobson, 1999, The mll–AF9 gene fusion in mice controls myeloproliferation and specifies acute myeloid leukaemogenesis, EMBO J., 18, 3564, 10.1093/emboj/18.13.3564 Lavau, 1997, Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX–ENL, EMBO J., 16, 4226, 10.1093/emboj/16.14.4226 Zeisig, 2004, Hoxa9 and Meis1 are key targets for MLL–ENL-mediated cellular immortalization, Mol. Cell. Biol., 24, 617, 10.1128/MCB.24.2.617-628.2004 Martin, 2003, Dimerization of MLL fusion proteins immortalizes hematopoietic cells, Cancer Cell, 4, 197, 10.1016/S1535-6108(03)00214-9 Slany, 1998, The oncogenic capacity of HRX–ENL requires the transcriptional transactivation activity of ENL and the DNA binding motifs of HRX, Mol. Cell. Biol., 18, 122, 10.1128/MCB.18.1.122 So, 2003, Dimerization contributes to oncogenic activation of MLL chimeras in acute leukemias, Cancer Cell, 4, 99, 10.1016/S1535-6108(03)00188-0 Schreiner, 1999, The leukemogenic fusion of MLL with ENL creates a novel transcriptional transactivator, Leukemia, 13, 1525, 10.1038/sj.leu.2401534 Zeisig, 2003, Transcriptional activation is a key function encoded by MLL fusion partners, Leukemia, 17, 359, 10.1038/sj.leu.2402804 Nie, 2003, Novel SWI/SNF chromatin-remodeling complexes contain a mixed-lineage leukemia chromosomal translocation partner, Mol. Cell. Biol., 23, 2942, 10.1128/MCB.23.8.2942-2952.2003 Debernardi, 2002, The MLL fusion partner AF10 binds GAS41, a protein that interacts with the human SWI/SNF complex, Blood, 99, 275, 10.1182/blood.V99.1.275 Erfurth, 2004, MLL fusion partners AF4 and AF9 interact at subnuclear foci, Leukemia, 18, 92, 10.1038/sj.leu.2403200 Lavau, 2000, Chromatin-related properties of CBP fused to MLL generated a myelodysplastic-like syndrome that evolves into myeloid leukemia, EMBO J., 19, 4655, 10.1093/emboj/19.17.4655 So, 2003, Common mechanism for oncogenic activation of MLL by forkhead family proteins, Blood, 101, 633, 10.1182/blood-2002-06-1785 So, 2002, MLL–AFX requires the transcriptional effector domains of AFX to transform myeloid progenitors and transdominantly interfere with forkhead protein function, Mol. Cell. Biol., 22, 6542, 10.1128/MCB.22.18.6542-6552.2002 Medema, 2000, AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1, Nature, 404, 782, 10.1038/35008115 Shilatifard, 1996, An RNA polymerase II elongation factor encoded by the human ELL gene, Science, 271, 1873, 10.1126/science.271.5257.1873 DiMartino, 2000, A carboxy-terminal domain of ELL is required and sufficient for immortalization of myeloid progenitors by MLL-ELL, Blood, 96, 3887, 10.1182/blood.V96.12.3887 Luo, 2001, The elongation domain of ELL is dispensable but its ELL-associated factor 1 interaction domain is essential for MLL-ELL-induced leukemogenesis, Mol. Cell. Biol., 21, 5678, 10.1128/MCB.21.16.5678-5687.2001 Dobson, 2000, Tumorigenesis in mice with a fusion of the leukaemia oncogene Mll and the bacterial lacZ gene, EMBO J., 19, 843, 10.1093/emboj/19.5.843 Ross, M.E. et al. (2004) Gene expression profiling of pediatric acute myelogenous leukemia. Blood Jun 29 [E published ahead of print] Thorsteinsdottir, 2002, Overexpression of the myeloid leukemia-associated Hoxa9 gene in bone marrow cells induces stem cell expansion, Blood, 99, 121, 10.1182/blood.V99.1.121 Sauvageau, 2001, Homeobox gene networks and the regulation of hematopoiesis, 133 Pineault, 2002, Differential expression of Hox, Meis1, and Pbx1 genes in primitive cells throughout murine hematopoietic ontogeny, Exp. Hematol., 30, 49, 10.1016/S0301-472X(01)00757-3 Nakamura, 1996, Cooperative activation of Hoxa and Pbx1-related genes in murine myeloid leukaemias, Nat. Genet., 12, 149, 10.1038/ng0296-149 Moskow, 1995, Meis1, a PBX1-related homeobox gene involved in myeloid leukemia in BXH-2 mice, Mol. Cell. Biol., 15, 5434, 10.1128/MCB.15.10.5434 Kroon, 1998, Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b, EMBO J., 17, 3714, 10.1093/emboj/17.13.3714 Schnabel, 2000, HoxA9-mediated immortalization of myeloid progenitors requires functional interactions with TALE cofactors Pbx and Meis, Oncogene, 19, 608, 10.1038/sj.onc.1203371 Armstrong, 2002, MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia, Nat. Genet., 30, 41, 10.1038/ng765 Rozovskaia, 2001, Upregulation of Meis1 and HoxA9 in acute lymphocytic leukemias with the t(4;11) abnormality, Oncogene, 20, 874, 10.1038/sj.onc.1204174 Yeoh, 2002, Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling, Cancer Cell, 1, 133, 10.1016/S1535-6108(02)00032-6 Ferrando, 2003, Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation, Blood, 102, 262, 10.1182/blood-2002-10-3221 Ayton, 2003, Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9, Genes Dev., 17, 2298, 10.1101/gad.1111603 So, 2003, Leukemic transformation of hematopoietic progenitors by MLL–GAS7 in the absence of Hoxa7 or Hoxa9, Blood, 103, 3192, 10.1182/blood-2003-10-3722 Kumar, 2003, Hoxa9 influences the phenotype but not the incidence of Mll–AF9 fusion gene leukemia, Blood, 103, 1823, 10.1182/blood-2003-07-2582